Categories
Publications & Presentations
Discover the main highlights of our industry in our latest publications.
Access to Care
Discover a complete record of access to care issues by region and PPTA activities in support of access to therapies.
Safety & Quality
Learn more about the regulatory policies and the Association’s voluntary standards for safety & quality standards.
Plasma Collection & Manufacturing
Learn more about plasma collection and discover certified plasma centers near you.
The Source Magazine
Subscribe to the international magazine of the plasma protein therapeutics industry.
Plasma FAQS
Get answers about plasma therapies and the processes surrounding donation and collection procedures.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Feb 16, 2022
PPTA Disagrees with Ruling from Romanian Competition Council
The Plasma Protein Therapeutics Association (PPTA) disagrees with the 15 February 2022 ruling from the Romanian Competition Council (RCC) finding that PPTA directed manufacturers to withhold immunoglobulin (Ig) therapies from the Romanian market to force repeal of the so-called “clawback” tax.
All
PPTA statements
Feb 16, 2022
PPTA Disagrees with Ruling from Romanian Competition Council
The Plasma Protein Therapeutics Association (PPTA) disagrees with the 15 February 2022 ruling from the Romanian Competition Council (RCC) finding that PPTA directed manufacturers to withhold immunoglobulin (Ig) therapies from the Romanian market to force repeal of the so-called “clawback” tax.
All
PPTA statements
Jan 1, 2022
2021 Annual Report
2021 Annual Report
All
PPTA Annual report
https://prezi.com/view/e2n8YKTCNdUS3BNcasJw/
Jan 1, 2022
2021 Annual Report
2021 Annual Report
All
PPTA Annual report
https://prezi.com/view/e2n8YKTCNdUS3BNcasJw/
Dec 17, 2021
A missed opportunity to acknowledge EU’s dependency on U.S. plasma
December 17, 2021 (Brussels, Belgium) — The Plasma Protein Therapeutics Association (PPTA) regrets that the publication of the European Commission report, “Study on medicine shortages,” does not include plasma, which is a biological starting material for the manufacture of lifesaving plasma-derived medicinal products (PDMPs).
All
Press releases
Dec 17, 2021
A missed opportunity to acknowledge EU’s dependency on U.S. plasma
December 17, 2021 (Brussels, Belgium) — The Plasma Protein Therapeutics Association (PPTA) regrets that the publication of the European Commission report, “Study on medicine shortages,” does not include plasma, which is a biological starting material for the manufacture of lifesaving plasma-derived medicinal products (PDMPs).
All
Press releases
Dec 1, 2021
The Source Winter 2021
Magazine of the Plasma Protein Therapeutics Industry - Winter 2021
All
The Source Magazine
https://drive.google.com/file/d/1le2D95C5zcS4gTIAPmTNSURxOSMfBFfM/view?usp=sharing
Dec 1, 2021
The Source Winter 2021
Magazine of the Plasma Protein Therapeutics Industry - Winter 2021
All
The Source Magazine
https://drive.google.com/file/d/1le2D95C5zcS4gTIAPmTNSURxOSMfBFfM/view?usp=sharing
No results found